PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |cirrhosis |
| Sentences | 144 |
| PubMedID- 22778970 | In the present systematic review, we explore the different aspects of the management of pvt in individuals with cirrhosis (excluding cases associated with hepatocellular carcinoma). |
| PubMedID- 22504244 | We describe a well-differentiated hepatocellular carcinoma (hcc) with alcohol-related liver cirrhosis in a 69-year-old man. |
| PubMedID- 22666283 | Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma. |
| PubMedID- 24040153 | Human hcv infection causes chronic liver disease, cirrhosis, and is associated with hepatocellular carcinoma 2. |
| PubMedID- 21528069 | Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma. |
| PubMedID- 22570565 | Transarterial chemoembolization (tace) is an established local therapy for managing unresectable hepatocellular carcinoma (hcc) in patients with advanced cirrhosis and confers significant survival benefits.1,2 iodized oil is usually used as a carrier of most anticancer agents to achieve preferential uptake and persistent deposit of the chemotherapeutic agent within the hcc nodules in conventional tace. |
| PubMedID- 25398070 | Risk of hepatocellular carcinoma also persists in patients with cirrhosis even if cure of hcv infection is achieved. |
| PubMedID- 22982095 | Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. |
| PubMedID- 23423240 | Portal vein thrombosis (pvt) is commonly associated with liver cirrhosis, irrespective of the presence of hepatocellular carcinoma (hcc). |
| PubMedID- 23118578 | The transcatheter arterial chemoembolization (tace) method has been widely used for the management of unresectable, advanced hepatocellular carcinoma (hcc) in patients with compensated liver cirrhosis (1). |
| PubMedID- 26223866 | In the case of hbv, 5 % of adults exposed to the virus develop chronic hbv infection, and cirrhosis and death because of hepatocellular carcinoma are important complications of chronic hbv infection . |
| PubMedID- 21210013 | Aim: the ultrasonographic (us) detection of hepatocellular carcinoma (hcc) in patients with liver cirrhosis is based on the visualization of focal lesions. |
| PubMedID- 21527064 | Since 85% of hepatocellular carcinoma (hcc) develops in patients with cirrhosis of the liver and its associated liver insufficiency, it is essential the hcc therapy spares uninvolved liver to minimize the risk of further compromise of hepatic function . |
| PubMedID- 21224679 | Treatment for hepatocellular carcinoma (hcc) with advanced cirrhosis, especially with hypersplenic thrombocytopenia, will be very difficult. |
| PubMedID- 24157306 | Hepatitis c virus (hcv) is a global health problem, affecting approximately 170 million, and results in a chronic degenerative liver disease that is characterised by hepatic fibrosis, cirrhosis and in 10% of cases hepatocellular carcinoma. |
| PubMedID- 23607898 | Aim: hepatectomy for hepatocellular carcinoma (hcc) in patients with primary biliary cirrhosis (pbc) has seldom been reported, and the clinical significance of this procedure remains unclear, although hcc has often been observed in end-stage pbc patients. |
| PubMedID- 23126044 | hepatocellular carcinoma mostly develops in patients with liver cirrhosis due to chronic hepatitis c virus (hcv) infection. |
| PubMedID- 20304209 | The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria. |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 25465804 | The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma. |
| PubMedID- 23479099 | Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy. |
| PubMedID- 20012230 | Methods: in this study, we enrolled 20 patients having liver cirrhosis with hepatocellular carcinoma and randomly assigned them into two groups to receive autologous stem cells or placebo. |
| PubMedID- 24202543 | 2009) and even higher among patients suffering from cryptogenic hepatitis or cryptogenic cirrhosis with hepatocellular carcinoma (10–74 %); (bokharaei-salim et al. |
| PubMedID- 23874878 | Hepatic steatosis can progress to non-alcoholic steatohepatitis (nash), cirrhosis and development of hepatocellular carcinoma. |
| PubMedID- 21389798 | Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. |
| PubMedID- 22226387 | Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over. |
| PubMedID- 23894275 | Nonalcoholic steatohepatitis (nash) often leads to cirrhosis and development of hepatocellular carcinoma. |
| PubMedID- 23164412 | It was shown 6 that oral antiviral therapy reduces the risk of hepatocellular carcinoma only in patients without cirrhosis, but could not protect patients with chronic infection. |
| PubMedID- 23396727 | cirrhosis co-exists with hepatocellular carcinoma in about 60% of patients and is equally common in the two sexes. |
| PubMedID- 21682829 | Furthermore, clinical trials have shown that sho-saiko-to lowers the rate of hepatocellular carcinoma (hcc) development in patients with cirrhosis and increases the survival of patients with hcc. |
| PubMedID- 21649567 | Conclusions: the incidence of hepatocellular carcinoma in patients with cirrhosis who have undergone a liver transplant at our hospital is similar to those reported in other studies. |
| PubMedID- 23146511 | Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient. |
| PubMedID- 20969743 | As of january, 2010, after a median follow-up of 16.7 months (iqr: 11.3-25.3), 13 new cases of decompensated cirrhosis, nine hepatocellular carcinomas and 20 hcv-related deaths were reported, resulting in a cumulative hcv-related severe event rate of 1.9/100 person-years (95% ci: 1.3-2.5). |
| PubMedID- 26042593 | Nash is characterized by steatosis, inflammation, hepatocyte death and at later stages fibrosis, cirrhosis, and the development of hepatocellular carcinoma (hcc) 5. |
| PubMedID- 25841913 | Management of liver cirrhosis in patients with hepatocellular carcinoma. |
| PubMedID- 26155261 | Backgrounds/aims: the prognosis of hepatic resection for hepatocellular carcinoma (hcc) in patients with cirrhosis is worse than in those without cirrhosis. |
| PubMedID- 23756865 | hepatocellular carcinoma is associated with cirrhosis and hepatic dysfunction in 80% of patients, which makes its prognosis and treatment more difficult than in many other cancers (sengupta and siddiqi, 2012). |
| PubMedID- 25725223 | Chronic hepatitis b virus (chb) infection can cause persistent hepatic inflammation and cirrhosis, which may lead to hepatocellular carcinoma (hcc). |
| PubMedID- 19345541 | Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. |
| PubMedID- 26017364 | The indications for lt were hepatocellular carcinoma with viral cirrhosis (n = 15), cirrhosis secondary to viral etiology (2), and alcoholic cirrhosis (2). |
| PubMedID- 20170495 | Hcv infection causes chronic liver disease, cirrhosis, and is associated with hepatocellular carcinoma 2. |
| PubMedID- 22923953 | association between chronic alcohol abuse, cirrhosis, and the development of hepatocellular carcinoma (hcc) is well documented. |
| PubMedID- 25891119 | The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system. |
| PubMedID- 22792259 | hepatocellular carcinoma is frequently associated with advanced cirrhosis due to chronic hepatitis c. progressive liver damage until hcc development in chronic hcv-infected patients encompasses deregulation of molecular pathways triggering malignant transformation. |
| PubMedID- 25894142 | Conclusions: patients transplanted for hepatitis b and d virus cirrhosis, even with hepatocellular carcinoma, had favorable prognosis and good longterm results. |
| PubMedID- 24223226 | Furthermore, bcaa supplementation has been suggested to prevent the incidence of hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 23775581 | From the baseline lic and serum ferritin reported ). |
| PubMedID- 23316254 | Demonstrate that sorafenib-induced th1 dominance can prevent the escape of tumor cells from the host immune system in liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc). |
| PubMedID- 24420645 | Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care. |
| PubMedID- 25751727 | Nash may progresss to fibrosis or cirrhosis and even liver-related mortality 7. |